232 related articles for article (PubMed ID: 32539773)
1. Development and validation of hybrid Brillouin-Raman spectroscopy for non-contact assessment of mechano-chemical properties of urine proteins as biomarkers of kidney diseases.
Gaipov A; Utegulov Z; Bukasov R; Turebekov D; Tarlykov P; Markhametova Z; Nurekeyev Z; Kunushpayeva Z; Sultangaziyev A
BMC Nephrol; 2020 Jun; 21(1):229. PubMed ID: 32539773
[TBL] [Abstract][Full Text] [Related]
2. Raman, Infrared and Brillouin Spectroscopies of Biofluids for Medical Diagnostics and for Detection of Biomarkers.
Aitekenov S; Sultangaziyev A; Abdirova P; Yussupova L; Gaipov A; Utegulov Z; Bukasov R
Crit Rev Anal Chem; 2023; 53(7):1561-1590. PubMed ID: 35157535
[TBL] [Abstract][Full Text] [Related]
3. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
4. Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by Glomerulopathies.
Kononikhin AS; Brzhozovskiy AG; Bugrova AE; Chebotareva NV; Zakharova NV; Semenov S; Vinogradov A; Indeykina MI; Moiseev S; Larina IM; Nikolaev EN
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110557
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Surface-Enhanced Raman Scattering Properties of Serum and Urine for the Detection of Chronic Kidney Disease in Patients.
Zong M; Zhou L; Guan Q; Lin D; Zhao J; Qi H; Harriman D; Fan L; Zeng H; Du C
Appl Spectrosc; 2021 Apr; 75(4):412-421. PubMed ID: 33031004
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression.
Ying T; Clayton P; Naresh C; Chadban S
BMC Nephrol; 2018 Mar; 19(1):55. PubMed ID: 29514605
[TBL] [Abstract][Full Text] [Related]
7. Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate.
Gil RB; Ortiz A; Sanchez-Niño MD; Markoska K; Schepers E; Vanholder R; Glorieux G; Schmitt-Kopplin P; Heinzmann SS
Nephrol Dial Transplant; 2018 Dec; 33(12):2156-2164. PubMed ID: 29554320
[TBL] [Abstract][Full Text] [Related]
8. Multisample Mass Spectrometry-Based Approach for Discovering Injury Markers in Chronic Kidney Disease.
Kim JE; Han D; Jeong JS; Moon JJ; Moon HK; Lee S; Kim YC; Yoo KD; Lee JW; Kim DK; Kwon YJ; Kim YS; Yang SH
Mol Cell Proteomics; 2021; 20():100037. PubMed ID: 33453410
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Online Liquid Chromatography-Surface-Enhanced Raman Scattering (LC-SERS) of Methotrexate and its Major Metabolites.
Subaihi A; Trivedi DK; Hollywood KA; Bluett J; Xu Y; Muhamadali H; Ellis DI; Goodacre R
Anal Chem; 2017 Jun; 89(12):6702-6709. PubMed ID: 28505414
[TBL] [Abstract][Full Text] [Related]
10. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
[TBL] [Abstract][Full Text] [Related]
11. Urine exosomal ceruloplasmin: a potential early biomarker of underlying kidney disease.
Gudehithlu KP; Hart P; Joshi A; Garcia-Gomez I; Cimbaluk DJ; Dunea G; Arruda JAL; Singh AK
Clin Exp Nephrol; 2019 Aug; 23(8):1013-1021. PubMed ID: 30955187
[TBL] [Abstract][Full Text] [Related]
12. Urinary Protein and Peptide Markers in Chronic Kidney Disease.
Chebotareva N; Vinogradov A; McDonnell V; Zakharova NV; Indeykina MI; Moiseev S; Nikolaev EN; Kononikhin AS
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830001
[TBL] [Abstract][Full Text] [Related]
13. Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.
Tabibzadeh N; Wagner S; Metzger M; Flamant M; Houillier P; Boffa JJ; Vrtovsnik F; Thervet E; Stengel B; Haymann JP;
Am J Kidney Dis; 2019 May; 73(5):596-604. PubMed ID: 30777634
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of urinary vascular endothelial growth factor (VEGF) on worsening kidney function in proteinuric chronic kidney disease.
Avguštin N; Rotar Ž; Pajek J; Kovač D; Osredkar J; Lindič J
Clin Nephrol; 2017 Supplement 1; 88(13):10-13. PubMed ID: 28601119
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation.
Milongo D; Bascands JL; Huart A; Esposito L; Breuil B; Moulos P; Siwy J; Ramírez-Torres A; Ribes D; Lavayssière L; Del Bello A; Muscari F; Alric L; Bureau C; Rostaing L; Schanstra JP; Kamar N
Liver Int; 2015 Jul; 35(7):1893-901. PubMed ID: 25515948
[TBL] [Abstract][Full Text] [Related]
16. [Urinary biomarkers of kidney dysfunction].
Piéroni L; Cristol JP
Ann Biol Clin (Paris); 2015; 73(2):151-7. PubMed ID: 25847736
[TBL] [Abstract][Full Text] [Related]
17. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
Hsu CY; Xie D; Waikar SS; Bonventre JV; Zhang X; Sabbisetti V; Mifflin TE; Coresh J; Diamantidis CJ; He J; Lora CM; Miller ER; Nelson RG; Ojo AO; Rahman M; Schelling JR; Wilson FP; Kimmel PL; Feldman HI; Vasan RS; Liu KD; ;
Kidney Int; 2017 Jan; 91(1):196-203. PubMed ID: 28029431
[TBL] [Abstract][Full Text] [Related]
18. Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial.
Cherney DZI; Dekkers CCJ; Barbour SJ; Cattran D; Abdul Gafor AH; Greasley PJ; Laverman GD; Lim SK; Di Tanna GL; Reich HN; Vervloet MG; Wong MG; Gansevoort RT; Heerspink HJL;
Lancet Diabetes Endocrinol; 2020 Jul; 8(7):582-593. PubMed ID: 32559474
[TBL] [Abstract][Full Text] [Related]
19. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.
Waikar SS; Srivastava A; Palsson R; Shafi T; Hsu CY; Sharma K; Lash JP; Chen J; He J; Lieske J; Xie D; Zhang X; Feldman HI; Curhan GC;
JAMA Intern Med; 2019 Apr; 179(4):542-551. PubMed ID: 30830167
[TBL] [Abstract][Full Text] [Related]
20. Brillouin Light Scattering: Development of a Near Century-Old Technique for Characterizing the Mechanical Properties of Materials.
Singaraju AB; Bahl D; Stevens LL
AAPS PharmSciTech; 2019 Feb; 20(3):109. PubMed ID: 30746575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
